<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01023568</url>
  </required_header>
  <id_info>
    <org_study_id>09-902</org_study_id>
    <nct_id>NCT01023568</nct_id>
  </id_info>
  <brief_title>Comparison of Direct Laryngoscopy, Truview EVO2 and Glidescope in Pediatric Patients</brief_title>
  <official_title>Comparison of Direct Laryngoscopy, Truview EVO2 and Glidescope in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of two novel videolaryngoscope
      systems, the Glidescope and the Truview PCD against standard direct laryngoscopy (DL) in
      pediatric patients. The investigators primary hypothesis is that the use of videolaryngoscope
      devices, Glidescope and Truview provide better laryngeal views in pediatric patients as
      measured by Cormack and ehane (C&amp;L) (1 to 4, 4 the worst), without increasing the time taken
      to intubate (TTI), compared with direct laryngoscopy (DL).

      The investigators secondary hypotheses are that the use of Glidescope and Truview PCD provoke
      less hemodynamic response and fewer episodes of de-saturation in pediatric patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Advances in airway management have led to development on videolaryngoscopy devices including
      the Glidescope® (Verathon Inc, Bothwell, USA), the AWD® (Pentax Corporation, Tokio, Japan)
      and most recently the Truview PCD (Truphatek International Ltd, Netanya, Israel). The use of
      videolaryngoscopy devices in adults have demonstrated some advantages including, minimal
      trauma on the airway and better view of the glottis.

      The Glidescope is designed with a 60º angle and a camera on the inferior aspect just at the
      inflection point. The view is obtained anteriorly and the camera is located remote from the
      glottis providing a good visual field. The video image is displayed on a Liquid Crystal
      Display (LCD), with electronic recording available. Despite a good experience using
      Glidescope in adults, few studies have been published in pediatric patients. Kim et al. in a
      randomized study comparing the use of Glidescope with direct laryngoscopy in children,
      demonstrated better or equal laryngoscopic view with longer time for intubation using the
      Glidescope.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was stopped for futility at the first interim analysis
  </why_stopped>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Successfully Intubate Patient.</measure>
    <time_frame>from start of intubation to successfully intubated up to 5 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Hemodynamic Response: Mean Arterial Blood Pressure</measure>
    <time_frame>measured at 1 minute interval at induction time and from intubation for 10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cormack-Lehane Grade</measure>
    <time_frame>immediately after intubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Hemodynamic Response: Heart Rate</measure>
    <time_frame>measured at 1 minute interval at induction time and from intubation for 10 minutes.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Experienced Desaturation</measure>
    <time_frame>measured at 1 minute interval at induction time and from intubation for 10 minutes.</time_frame>
    <description>Desaturation was defined as SpO2 less than 90% at induction time or any time from intubation to 10 minutes after</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">134</enrollment>
  <condition>Intubation</condition>
  <arm_group>
    <arm_group_label>Macintosh blade</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intubation with Macintosh blade laryngoscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glidescope</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intubation with Glidescope laryngoscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Truview PCD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intubation with the Truview PCD laryngoscope</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Macintosh blade</intervention_name>
    <description>Intubation with Macintosh blade laryngoscope</description>
    <arm_group_label>Macintosh blade</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Glidescope</intervention_name>
    <description>Intubation with Glidescope laryngoscope.</description>
    <arm_group_label>Glidescope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Truview PCD</intervention_name>
    <description>Intubation with Truview PCD laryngoscope.</description>
    <arm_group_label>Truview PCD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I-III

          -  elective general surgical procedures

          -  from 0-10 years-old

        Exclusion Criteria:

          -  increase intracranial pressure

          -  history of severe gastrointestinal reflux

          -  sore throat

          -  upper respiratory airway infection

          -  known or suspected difficult airway or coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie Niezgoda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2009</study_first_submitted>
  <study_first_submitted_qc>December 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2009</study_first_posted>
  <results_first_submitted>June 21, 2016</results_first_submitted>
  <results_first_submitted_qc>December 8, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 2, 2017</results_first_posted>
  <last_update_submitted>December 8, 2016</last_update_submitted>
  <last_update_submitted_qc>December 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intubation</keyword>
  <keyword>pediatric</keyword>
  <keyword>videolaryngoscope devices</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Macintosh Blade</title>
          <description>Intubation with Macintosh blade laryngoscope
Macintosh blade: Intubation with Macintosh blade laryngoscope</description>
        </group>
        <group group_id="P2">
          <title>Glidescope</title>
          <description>Intubation with Glidescope laryngoscope
Glidescope: Intubation with Glidescope laryngoscope.</description>
        </group>
        <group group_id="P3">
          <title>Truview PCD</title>
          <description>Intubation with the Truview PCD laryngoscope
Truview PCD: Intubation with Truview PCD laryngoscope.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="44"/>
                <participants group_id="P3" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="44"/>
                <participants group_id="P3" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Macintosh Blade</title>
          <description>Intubation with Macintosh blade laryngoscope
Macintosh blade: Intubation with Macintosh blade laryngoscope</description>
        </group>
        <group group_id="B2">
          <title>Glidescope</title>
          <description>Intubation with Glidescope laryngoscope
Glidescope: Intubation with Glidescope laryngoscope.</description>
        </group>
        <group group_id="B3">
          <title>Truview PCD</title>
          <description>Intubation with the Truview PCD laryngoscope
Truview PCD: Intubation with Truview PCD laryngoscope.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="45"/>
            <count group_id="B4" value="134"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.0" spread="2.8"/>
                    <measurement group_id="B2" value="4.6" spread="2.7"/>
                    <measurement group_id="B3" value="5.2" spread="2.8"/>
                    <measurement group_id="B4" value="4.6" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="31"/>
                    <measurement group_id="B4" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17" lower_limit="15" upper_limit="19"/>
                    <measurement group_id="B2" value="16" lower_limit="15" upper_limit="18"/>
                    <measurement group_id="B3" value="16" lower_limit="16" upper_limit="18"/>
                    <measurement group_id="B4" value="16.5" lower_limit="15.4" upper_limit="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA physical status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>I: A normal healthy patient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>II: A patient with mild systemic disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>III: A patient with severe systemic disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to Successfully Intubate Patient.</title>
        <time_frame>from start of intubation to successfully intubated up to 5 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Macintosh Blade</title>
            <description>Intubation with Macintosh blade laryngoscope
Macintosh blade: Intubation with Macintosh blade laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Intubation with Glidescope laryngoscope
Glidescope: Intubation with Glidescope laryngoscope.</description>
          </group>
          <group group_id="O3">
            <title>Truview PCD</title>
            <description>Intubation with the Truview PCD laryngoscope
Truview PCD: Intubation with Truview PCD laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Successfully Intubate Patient.</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="21" upper_limit="28"/>
                    <measurement group_id="O2" value="39" lower_limit="31" upper_limit="59"/>
                    <measurement group_id="O3" value="44" lower_limit="28" upper_limit="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The GlideScope and Truview PCD video laryngoscopes were individually assessed for non-inferiority on time to intubation vs direct laryngoscopy at the 0.025 significance level using an a priori specified non-inferiority delta of seven seconds (about 40% of the expected standard deviation of 18 sec and not thought to be clinically important).</non_inferiority_desc>
            <p_value>&gt;0.99</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>14</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>7</ci_lower_limit>
            <ci_upper_limit>26</ci_upper_limit>
            <estimate_desc>Glidescope - direct laryngoscopy</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The GlideScope and Truview PCD video laryngoscopes were individually assessed for non-inferiority on time to intubation vs direct laryngoscopy at the 0.025 significance level using an a priori specified non-inferiority delta of seven seconds (about 40% of the expected standard deviation of 18 sec and not thought to be clinically important).</non_inferiority_desc>
            <p_value>&gt;0.99</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>17</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>6</ci_lower_limit>
            <ci_upper_limit>28</ci_upper_limit>
            <estimate_desc>Truview PCD - direct laryngoscopy</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Hemodynamic Response: Mean Arterial Blood Pressure</title>
        <time_frame>measured at 1 minute interval at induction time and from intubation for 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Macintosh Blade</title>
            <description>Intubation with Macintosh blade laryngoscope
Macintosh blade: Intubation with Macintosh blade laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Intubation with Glidescope laryngoscope
Glidescope: Intubation with Glidescope laryngoscope.</description>
          </group>
          <group group_id="O3">
            <title>Truview PCD</title>
            <description>Intubation with the Truview PCD laryngoscope
Truview PCD: Intubation with Truview PCD laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Hemodynamic Response: Mean Arterial Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" spread="12"/>
                    <measurement group_id="O2" value="63" spread="9"/>
                    <measurement group_id="O3" value="66" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.28</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cormack-Lehane Grade</title>
        <time_frame>immediately after intubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Macintosh Blade</title>
            <description>Intubation with Macintosh blade laryngoscope
Macintosh blade: Intubation with Macintosh blade laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Intubation with Glidescope laryngoscope
Glidescope: Intubation with Glidescope laryngoscope.</description>
          </group>
          <group group_id="O3">
            <title>Truview PCD</title>
            <description>Intubation with the Truview PCD laryngoscope
Truview PCD: Intubation with Truview PCD laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Cormack-Lehane Grade</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1: Full view of glottis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2: Partial view of glottis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3: Only epiglottis seen, none of glottis seen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4: Neither glottis nor epiglottis seen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The Cormack-Lehane grade with a grade 1 (best grade) to 4 (worst grade) was analyzed as an ordinal outcome.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt; 0.99</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>1-tailed Wilcoxon sum-rank test</method_desc>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1</ci_lower_limit>
            <ci_upper_limit>2</ci_upper_limit>
            <estimate_desc>The median difference was Hodges-Lehmann estimation and the confidence intervals were exact confidence limits. The SAS &quot;NPAR1WAY&quot; procedure was used for test and estimation.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The Cormack-Lehane grade with a grade 1 (best grade) to 4 (worst grade) was analyzed as an ordinal outcome.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.18</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>1-tailed Wilcoxon sum-rank test</method_desc>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0</ci_lower_limit>
            <ci_upper_limit>0</ci_upper_limit>
            <estimate_desc>The median difference was Hodges-Lehmann estimation and the confidence intervals were exact confidence limits. The SAS &quot;NPAR1WAY&quot; procedure was used for test and estimation.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Hemodynamic Response: Heart Rate</title>
        <time_frame>measured at 1 minute interval at induction time and from intubation for 10 minutes.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Macintosh Blade</title>
            <description>Intubation with Macintosh blade laryngoscope
Macintosh blade: Intubation with Macintosh blade laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Intubation with Glidescope laryngoscope
Glidescope: Intubation with Glidescope laryngoscope.</description>
          </group>
          <group group_id="O3">
            <title>Truview PCD</title>
            <description>Intubation with the Truview PCD laryngoscope
Truview PCD: Intubation with Truview PCD laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Hemodynamic Response: Heart Rate</title>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126" spread="21"/>
                    <measurement group_id="O2" value="127" spread="15"/>
                    <measurement group_id="O3" value="128" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.26</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Experienced Desaturation</title>
        <description>Desaturation was defined as SpO2 less than 90% at induction time or any time from intubation to 10 minutes after</description>
        <time_frame>measured at 1 minute interval at induction time and from intubation for 10 minutes.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Macintosh Blade</title>
            <description>Intubation with Macintosh blade laryngoscope
Macintosh blade: Intubation with Macintosh blade laryngoscope</description>
          </group>
          <group group_id="O2">
            <title>Glidescope</title>
            <description>Intubation with Glidescope laryngoscope
Glidescope: Intubation with Glidescope laryngoscope.</description>
          </group>
          <group group_id="O3">
            <title>Truview PCD</title>
            <description>Intubation with the Truview PCD laryngoscope
Truview PCD: Intubation with Truview PCD laryngoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Experienced Desaturation</title>
          <description>Desaturation was defined as SpO2 less than 90% at induction time or any time from intubation to 10 minutes after</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.99</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Macintosh Blade</title>
          <description>Intubation with Macintosh blade laryngoscope
Macintosh blade: Intubation with Macintosh blade laryngoscope</description>
        </group>
        <group group_id="E2">
          <title>Glidescope</title>
          <description>Intubation with Glidescope laryngoscope
Glidescope: Intubation with Glidescope laryngoscope.</description>
        </group>
        <group group_id="E3">
          <title>Truview PCD</title>
          <description>Intubation with the Truview PCD laryngoscope
Truview PCD: Intubation with Truview PCD laryngoscope.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Roberta Johnson</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>216-444-9950</phone>
      <email>johnsor13@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

